TCRT-ESO-A2

N/A

Report date: 2023/02/14 17:40:22

Base Information

Drug NameTCRT-ESO-A2

Drug Alias NameTCRT-ESO-A2

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy

Mechanisms of ActionAnti-NY-ESO-1

TargetsCancer/testis antigen 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAthenex Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAthenex Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A